A Woman's Journey: Sunshine on a Rainy Day — Avoiding Melanoma
Follow us on Twitter to join the conversation: @HopkinsatHome, #HopkinsatHome
REGISTER HERE to join the livestream on Tuesday, June 8 at 7-8 p.m. EDT
The American Cancer Society estimates that in the United States in 2020, more than 100,000 new melanomas will be diagnosed and approximately 6,850 people will die of the disease. Before hitting the beach to celebrate summer, listen as oncologist William Sharfman reviews the risks, signs and symptoms of melanoma. Sharfman also discusses melanoma research and treatment protocols, as well as novel therapies for high risk patients with advanced melanoma.
William Sharman, M.D. is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology, gastrointestinal cancers and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients; GI cancers; and lung cancer.